Esmolol patient counseling information: Difference between revisions

Latest revision as of 19:52, 21 July 2014

Redirect to:

@@ Line 1: / Line 1: @@
-__NOTOC__
+#REDIRECT [[Esmolol#Patient Counseling Information]]
-{{Esmolol}}
-{{CMG}}; {{AE}} {{AZ}}
-==Patient Counseling Information==
-Physicians should inform patients of the risks associated with BREVIBLOC injection:
-The most common adverse reactions are symptomatic [[hypotension]] ([[hyperhidrosis]], [[dizziness]]), and asymptomatic hypotension.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher =  | date =  | accessdate = }}</ref>
-==References==
-{{Reflist}}
-{{FDA}}
+[[Category:Beta blockers]]
 [[Category:Cardiovascular Drugs]]
 [[Category:Drugs]]